biolitec®“s anal fistula therapy enables most gentle treatment – convinces through patient-friendly therapeutic process – low-risk laser treatment – targets only affected tissue
Jena, October 8, 2014 – An estimate of 15.000 people a year suffers from anal fistulas or anal abscesses. First symptoms such as itching, high temperature, bleeding, or secretion are often ignored until they become unbearable. The diagnosis confronts patients with a discomforting topic.
When being diagnosed with anal fistula, patients might feel insecure about the treatment considering that there might be side effects or consequences such as a long and painful period of recovery, limited mobility or symptoms of incontinence.
However, there is a solution offered: As one of the leading companies worldwide in the field of laser applications, biolitec® has done pioneer work by successfully launching the minimally invasive FiLaC® laser therapy. In order to be able to offer patients the most advanced therapy, many proctologists already make use of FiLaC®.
FiLaC® aims at removing the fistula precisely without damaging the surrounding tissue. The laser probe which is used during the procedure is especially flexible and can be used regardless of the fistula“s size and length. The sphincter muscle tissue stays intact. Through this most innovative method, FiLaC® can lessen side effects and may contribute to a fast relief, a shorter period of recovery and a quicker return to the daily routine.
Depending on which country you live in, the costs may be covered by your health insurance. Please consult your physician.
For further information on the gentle laser therapy by biolitec® please visit www.info-analfistel.com. If you have questions, please do not hesitate to contact us at post@info-analfistel.de or call the biolitec® hotline at +49(0)1805-010276.
About biolitec®:
biolitec AG is one of the leading companies worldwide in the field of medical laser treatments and the only provider that possesses all relevant core competencies – photosensitizers, laser devices and optical fibers – in the field of photodynamic therapy (PDT). Besides laser-based treatment of cancer with the drug Foscan®, biolitec AG primarily researches on minimally-invasive and gentle laser treatments and markets them. ELVeS Radial™ (Endo Laser Vein System) is the most often used laser system worldwide for the treatment of varicose veins. In combination with the Ceralas® HPD laser, the innovative contact fiber XCAVATOR™ enables a gentle treatment of e.g. benign prostatic hyperplasia (BPH) in urology. The new LEONARDO® diode laser by biolitec® is the first universally applicable medical laser which features a combination of two wavelengths, 980nm and 1470nm, and is suitable for interdisciplinary use. Gentle laser treatments in the fields of proctology, ENT, gynecology, thoracic surgery as well as pneumology also belong to the business field of biolitec AG. Further information at www.biolitec.com.
Kontakt
biolitec AG
Jörn Gleisner
Otto-Schott-Straße 15
07745 Jena
+49 (0) 3641/5195336
info@biolitec.de
http://www.biolitec.de